Proprio Vision Stock

Proprio uses machine learning, computer vision, and augmented reality user interfaces to improve the accuracy and efficiency of surgery

Sign up today and learn more about Proprio Vision Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Proprio Vision Stock

Proprio is a Seattle-based company utilizing machine learning, automated intelligence, and mixed-reality user interfaces to develop a next generation surgical navigation and imaging platform to improve surgical accuracy, simplify surgical workflows, and improve patient outcomes. The solution we’re building supplants surgical microscopes, navigation systems, loupes, and screens, etc. Replacing surgical microscopes alone wouldn’t be a compelling enough goal for us though. Our greater vision is to move medicine out of the past and into a future that fully leverages not only existing technologies, like AR/VR, but one where medical innovation can move at the pace of software development in other industries. In order to realize that future, we have to move away from a dependency on ground glass, in the case of microscopes, and toward a focus on software and data, and leverage the emerging capabilities of computer vision and machine learning to enhance the combined performance of humans and computers. That’s our mission.


Funding History

January 2019$7.0M
June 2020$23.0M


CEO& Co-Founder

Gabriel Jones


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: